Literature DB >> 30585173

An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.

Naoya Ieda1, Kaoru Itoh1, Yasumichi Inoue1, Yusuke Izumiya2, Mitusyasu Kawaguchi1, Naoki Miyata1, Hidehiko Nakagawa3.   

Abstract

Pin1 (protein interacting with never in mitosis A-1) is a member of the peptidyl prolyl isomerase (PPIase) family, and catalyzes cis-trans isomerization of pThr/Ser-Pro amide bonds. Because Pin1 is overexpressed in various cancer cell lines and promotes cell growth, it is considered a target for anticancer agents. Here, we designed and synthesized a covalently binding Pin1 inhibitor (S)-2 to target Pin1's active site. This compound inhibited Pin1 in protease-coupled assay, and formed a covalent bond with Cys113 of Pin1, as determined by ESI-MS. The acetoxymethyl ester of (S)-2, i.e., 6, suppressed cyclin D1 expression in human prostate cancer PC-3 cells, and exhibited cytotoxicity. Pin1-knockdown experiments indicated that a target for the cytotoxicity of 6 is Pin1.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Covalent bond; Cysteine; Irreversible inhibition; Michael acceptor; Peptidyl prolyl isomerase

Year:  2018        PMID: 30585173     DOI: 10.1016/j.bmcl.2018.12.044

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  A Phosphoramidate Strategy Enables Membrane Permeability of a Non-nucleotide Inhibitor of the Prolyl Isomerase Pin1.

Authors:  Daniel M C Schwarz; Sarah K Williams; Maxwell Dillenburg; Carston R Wagner; Jason E Gestwicki
Journal:  ACS Med Chem Lett       Date:  2020-08-10       Impact factor: 4.345

Review 2.  Mission Possible: Advances in MYC Therapeutic Targeting in Cancer.

Authors:  Brittany L Allen-Petersen; Rosalie C Sears
Journal:  BioDrugs       Date:  2019-10       Impact factor: 5.807

3.  Identification of a potent and selective covalent Pin1 inhibitor.

Authors:  Zainab M Doctor; Behnam Nabet; Benika J Pinch; Christopher M Browne; Hyuk-Soo Seo; Mikaela L Mohardt; Shingo Kozono; Xiaolan Lian; Theresa D Manz; Yujin Chun; Shin Kibe; Daniel Zaidman; Dina Daitchman; Zoe C Yeoh; Nicholas E Vangos; Ezekiel A Geffken; Li Tan; Scott B Ficarro; Nir London; Jarrod A Marto; Stephen Buratowski; Sirano Dhe-Paganon; Xiao Zhen Zhou; Kun Ping Lu; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2020-06-01       Impact factor: 15.040

Review 4.  Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.

Authors:  Hsiang-Hao Chuang; Yen-Yi Zhen; Yu-Chen Tsai; Cheng-Hao Chuang; Ming-Shyan Huang; Michael Hsiao; Chih-Jen Yang
Journal:  Biomedicines       Date:  2021-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.